These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 12797255)

  • 1. Fetal hyperechogenic bowel and Down's syndrome.
    Nyberg DA; Resta RG; Mahony BS; Dubinsky T; Luthy DA; Hickok DE; Luthardt FW
    Ultrasound Obstet Gynecol; 1993 Sep; 3(5):330-3. PubMed ID: 12797255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between an abnormal nuchal skin fold, trisomy 21, and ultrasound abnormalities identified during the second trimester of pregnancy.
    DeVore GR; Alfi O
    Ultrasound Obstet Gynecol; 1993 Nov; 3(6):387-94. PubMed ID: 12797239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal mild idiopathic lateral ventriculomegaly: is there a correlation with fetal trisomy?
    Achiron R; Schimmel M; Achiron A; Mashiach S
    Ultrasound Obstet Gynecol; 1993 Mar; 3(2):89-92. PubMed ID: 12797298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
    Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-natal counselling and diagnosis in Down's syndrome.
    Papp Z
    Med Gynaecol Androl Sociol; 1973; 7(4):10-5. PubMed ID: 12156379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
    Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
    BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal use of nutritional supplements during the first month of pregnancy and decreased risk of Down's syndrome: case-control study.
    Czeizel AE; Puhó E
    Nutrition; 2005 Jun; 21(6):698-704; discussion 774. PubMed ID: 15925294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal pyelectasis: does fetal gender modify the risk of major trisomies?
    Bornstein E; Barnhard Y; Donnenfeld A; Ferber A; Divon MY
    Obstet Gynecol; 2006 Apr; 107(4):877-9. PubMed ID: 16582126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal hyperechogenic bowel following intra-amniotic bleeding.
    Sepulveda W; Hollingsworth J; Bower S; Vaughan JI; Fisk NM
    Obstet Gynecol; 1994 Jun; 83(6):947-50. PubMed ID: 8190437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S; Chandeying V
    J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal hyperechogenic bowel may indicate congenital cytomegalovirus disease responsive to immunoglobulin therapy.
    Nigro G; Adler SP; Gatta E; Mascaretti G; Megaloikonomou A; La Torre R; Necozione S
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2202-5. PubMed ID: 22506668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of sonographically detected second-trimester choroid plexus cysts: a series of 211 cases and a review of the literature.
    Nava S; Godmilow L; Reeser S; Ludomirsky A; Donnenfeld AE
    Ultrasound Obstet Gynecol; 1994 Nov; 4(6):448-51. PubMed ID: 12797123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Nicolaides' risk evaluation for Down's syndrome with a novel software: an analysis of 1,463 cases.
    Schmidt P; Staboulidou I; Soergel P; Wüstemann M; Hillemanns P; Scharf A
    Arch Gynecol Obstet; 2007 Jun; 275(6):469-74. PubMed ID: 17333228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal outcomes associated with intestinal abnormalities diagnosed by fetal ultrasound.
    Ruiz MJ; Thatch KA; Fisher JC; Simpson LL; Cowles RA
    J Pediatr Surg; 2009 Jan; 44(1):71-4; discussion 74-5. PubMed ID: 19159720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the risk of Down's syndrome in antenatal screening and the gestation at which this risk applies.
    Morris JK; Wald NJ
    J Med Screen; 2007; 14(1):5-7. PubMed ID: 17362564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second trimester prenatal ultrasound for the detection of pregnancies at increased risk of Trisomy 18 based on serum screening.
    Cho RC; Chu P; Smith-Bindman R
    Prenat Diagn; 2009 Feb; 29(2):129-39. PubMed ID: 19142904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
    Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O
    Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnant women of 35 years of age or more: maternal serum markers or amniocentesis?
    Antsaklis A; Papantoniou N; Mesogitis S; Michalas S; Aravantinos D
    J Obstet Gynaecol; 1999 May; 19(3):253-6. PubMed ID: 15512289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of detailed first trimester ultrasound examination in abnormal fetal nuchal translucency.
    Bronshtein M; Zimmer EZ; Blazer S
    Prenat Diagn; 2008 Nov; 28(11):1037-41. PubMed ID: 18925580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.